Search - tctmd.com

Displaying 21 - 40 of 3194

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1424: Transcatheter Aortic Valve Replacement (TAVR) With JenaValve Trilogy System for Aortic Regurgitation Following a David Procedure

Presenter: Chih-Fan Yeh

October 28, 2025

Presentation TCT 2025

TCT 19: Long-Term Clinical Outcomes Following Transcatheter Aortic Valve Replacement (TAVR): A Decade of Data

Presenter: Judah Rajendran

October 28, 2025

Presentation TCT 2025

TCT 167: The predictive value of complement C1q/tumor necrosis factor-related protein 9 in combination with aortic valve calcification in coronary artery calcification

Presenter: Manish Narang

October 28, 2025

Presentation TCT 2025

TCT 14: Improved Survival but Higher Complication Rates in Women Undergoing TAVR: A Long-Term Sex-Based Outcome Analysis

Presenter: Mehmet Cilingiroglu

October 28, 2025

Presentation TCT 2025

TCT 1386: A Triple TAVR Trouble: When Bleeding Infection and Valve Disease Collide

Presenter: Eloina Baltazar

October 28, 2025

Presentation TCT 2025

TCT 1167: Feasibility of Transcatheter Aortic Valve Replacement Using a Balloon Expandable Valve in Patients with Prior Endovascular Aortic Stent Grafts

Presenter: Iad Alhallak

October 28, 2025

Presentation TCT 2025

TCT 1166: TRANSCATHETER AORTIC VALVE IMPLANTATION IN A HOSPITAL WITHOUT ON-SITE CARDIAC SURGERY - THE FIRST ITALIAN SINGLE-CENTER EXPERIENCE

Presenter: Giandomenico Mancini

October 28, 2025

Presentation TCT 2025

First-in-Human Trial of Robotic-Assisted Transcatheter Aortic Valve Replacement

Presenter: Yan Wang

October 28, 2025

Presentation TCT 2025

TCT 1382: Rescuing Suicide Left Ventricle Post-TAVR: Emergent Mitral Edge‑to‑Edge Repair and Valve Post‑Dilation Restore Hemodynamic Stability

Presenter: Teja Sanjiv Chakrala

October 28, 2025

Presentation TCT 2025

Aortic Valve Guidelines

Presenter: Fabien Praz

October 28, 2025

Presentation TCT 2025

TCT 1165: Feasibility of Percutanous And Non-Fluoroscopic (PAN) Transcatheter Aortic Valve Replacement

Presenter: Jie Dong

October 28, 2025

Presentation TCT 2025

TCT 119: Impact of Depth of implantation to Membranous Interventricular Septum Ratio on the Incidence of Conduction Disturbance after Transcatheter Aortic Valve Replacement

Presenter: Ayman K M. Hassan

October 28, 2025

Presentation TCT 2025

TCT 1189: The Impact of Concomitant Mitral Regurgitation on Cardiovascular Events and Mortality After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis

Presenter: Mohammad Reza Movahed

October 28, 2025

Presentation TCT 2025

TCT 844: Severe Aortic Stenosis: Who Does Not Undergo Aortic Valve Replacement?

Presenter: William Downey

October 28, 2025

Presentation TCT 2025

TCT 1192: Safety and Efficacy of Combined Transcatheter Aortic and Mitral Valve Replacement: Insights from a Single-Center Case Series

Presenter: Cedrick Mutebi

October 28, 2025

Presentation TCT 2025

TCT 1193: Balloon-Expandable Versus Self-Expandable Transcatheter Aortic Valve Replacement In Patients With Concomitant Mitral Regurgitation

Presenter: Temirlan Erkenov

October 28, 2025

Presentation TCT 2025

TCT 1191: Long-term Impact of Multivalvular Heart Disease in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Quentin BATTISTOLO

October 28, 2025

Presentation TCT 2025

TCT 1187: Perioperative Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement With Concomitant Mitral Regurgitation Revealing Improving Mitral Regurgitation: A Meta-Analysis

Presenter: Mohammad Reza Movahed

October 28, 2025

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Advertisement

TCT 1424: Transcatheter Aortic Valve Replacement (TAVR) With JenaValve Trilogy System for Aortic Regurgitation Following a David Procedure

TCT 19: Long-Term Clinical Outcomes Following Transcatheter Aortic Valve Replacement (TAVR): A Decade of Data

TCT 167: The predictive value of complement C1q/tumor necrosis factor-related protein 9 in combination with aortic valve calcification in coronary artery calcification

TCT 14: Improved Survival but Higher Complication Rates in Women Undergoing TAVR: A Long-Term Sex-Based Outcome Analysis

TCT 1386: A Triple TAVR Trouble: When Bleeding Infection and Valve Disease Collide

TCT 1167: Feasibility of Transcatheter Aortic Valve Replacement Using a Balloon Expandable Valve in Patients with Prior Endovascular Aortic Stent Grafts

TCT 1166: TRANSCATHETER AORTIC VALVE IMPLANTATION IN A HOSPITAL WITHOUT ON-SITE CARDIAC SURGERY - THE FIRST ITALIAN SINGLE-CENTER EXPERIENCE

First-in-Human Trial of Robotic-Assisted Transcatheter Aortic Valve Replacement

TCT 1382: Rescuing Suicide Left Ventricle Post-TAVR: Emergent Mitral Edge‑to‑Edge Repair and Valve Post‑Dilation Restore Hemodynamic Stability

Aortic Valve Guidelines

TCT 1165: Feasibility of Percutanous And Non-Fluoroscopic (PAN) Transcatheter Aortic Valve Replacement

TCT 119: Impact of Depth of implantation to Membranous Interventricular Septum Ratio on the Incidence of Conduction Disturbance after Transcatheter Aortic Valve Replacement

TCT 1189: The Impact of Concomitant Mitral Regurgitation on Cardiovascular Events and Mortality After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis

TCT 844: Severe Aortic Stenosis: Who Does Not Undergo Aortic Valve Replacement?

TCT 1192: Safety and Efficacy of Combined Transcatheter Aortic and Mitral Valve Replacement: Insights from a Single-Center Case Series

TCT 1193: Balloon-Expandable Versus Self-Expandable Transcatheter Aortic Valve Replacement In Patients With Concomitant Mitral Regurgitation

TCT 1191: Long-term Impact of Multivalvular Heart Disease in Patients Undergoing Transcatheter Aortic Valve Replacement

TCT 1187: Perioperative Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement With Concomitant Mitral Regurgitation Revealing Improving Mitral Regurgitation: A Meta-Analysis

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content